Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Aug 1;276(2):222-223.
doi: 10.1097/SLA.0000000000005504. Epub 2022 Jul 6.

Prediction of R Status in Resections for Pancreatic Cancer Using Simplified Radiological Criteria: Not So Simple

Alice C Wei  1 , William R Jarnagin
Affiliations
Editorial

Prediction of R Status in Resections for Pancreatic Cancer Using Simplified Radiological Criteria: Not So Simple

Alice C Wei et al. Ann Surg. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest

Comment on

References

    1. Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol. 2019;10:10–27. - PMC - PubMed
    1. Von Hoff DD, Ervin T, Arena FP, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 2013;369: 1691–1703. - PMC - PubMed
    1. Conroy T, Hammel P, Hebbar M, et al. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer. N Engl J Med. 2018;379: 2395–2406. - PubMed
    1. Tempero MA, Malafa MP, Al-Hawary M, et al. Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19:439–457. - PubMed
    1. Bolm L, Pisuchpen N, Qadan M, et al. Prediction of R status in resections for pancreatic cancer using simplified radiological criteria. Ann Surg. 2022;276:215–221. - PubMed